Luis Miguel Gutierrez Robledo

Prof. Luis Miguel Gutierrez Robledo

Instituto Nacional de Geriatría, México, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
JMJohn E. Morley
John E. Morley
BVBruno Vellas
Bruno Vellas
GKG. Abellan van Kan
G. Abellan van Kan
SAStefan D. Anker
Stefan D. Anker
JBJuergen M. Bauer
Juergen M. Bauer
JWJeremy Walston
Jeremy Walston

1 February 2015 in The Lancet
Verified
Journal Article
Closed access
MPMartin J Prince
Martin J Prince
FWFan Wu
Fan Wu
YGYanfei Guo
Yanfei Guo
LRLuis Miguel Gutierrez Robledo
Luis Miguel Gutierrez Robledo
MOMartin O'DOnnell
Martin O'DOnnell
SYSalim Yusuf
Salim Yusuf

16 April 2012 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
LMLeocadio Rodríguez Mañas
Leocadio Rodríguez Mañas
Catherine FéartCatherine Féart
Catherine Féart
GMGiovanni Mann
Giovanni Mann
VJVINA JOSE
VINA JOSE
SCSomnath Chatterji
Somnath Chatterji
EVEnrique Vega
Enrique Vega
There is no consensus regarding the definition of frailty for clinical uses. A modified Delphi process was used to attempt to achieve consensus definition. Experts were selected from different fields and organized into five Focus Groups. A questionnaire was developed and sent to experts in the area of frailty. Responses and comments were analyzed using a pre-established strategy. Statements with an agreement more than or equal to 80% were accepted. Overall, 44% of the statements regarding the concept of frailty and 18% of the statements regarding diagnostic criteria were accepted. There was consensus on the value of screening for frailty and about the identification of six domains of frailty for inclusion in a clinical definition, but no agreement was reached concerning a specific set of clinical/laboratory biomarkers useful for diagnosis. There is agreement on the usefulness of defining frailty in clinical settings as well as on its main dimensions. However, additional research is needed before an operative definition of frailty can be established.

1 March 2016 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
Matteo  CesariMatteo Cesari
Matteo Cesari
MPMartin Prince
Martin Prince
JTJotheeswaran Amuthavalli Thiyagarajan
Jotheeswaran Amuthavalli Thiyagarajan
ICIslene Araujo De Carvalho
Islene Araujo De Carvalho
RBRoberto Bernabei
Roberto Bernabei
BVBruno Vellas
Bruno Vellas

3 March 2009 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JAJosé Alberto AVILA-FUNES
José Alberto AVILA-FUNES
HAHélène Amieva
Hélène Amieva
PBPascale Barberger‐Gateau
Pascale Barberger‐Gateau
MGMélanie Le Goff
Mélanie Le Goff
NRNadine Raoux
Nadine Raoux
JDJean‐François Dartigues
Jean‐François Dartigues

1 July 2012 in Journal of the American Medical Directors Association
Verified
Journal Article
Open access
ASAlan Sinclair
Alan Sinclair
JMJohn E. Morley
John E. Morley
LMLeocadio Rodríguez Mañas
Leocadio Rodríguez Mañas
Giuseppe PaolissoGiuseppe Paolisso
Giuseppe Paolisso
TBTony Bayer
Tony Bayer
KLKate Lorig
Kate Lorig
Diabetes mellitus is a highly prevalent metabolic condition in ageing societies associated with high levels of morbidity, multiple therapies, and functional deterioration that challenges even the best of health care systems to deliver high-quality, individualized care. Most international clinical guidelines have ignored the often-unique issues of frailty, functional limitation, changes in mental health, and increasing dependency that characterize many aged patients with diabetes. A collaborative Expert Group of the IAGG and EDWPOP and an International Task Force have explored the key issues that affect diabetes in older people using a robust method comprising a Delphi process and an evidence-based review of the literature. Eight domains of interest were initially agreed and discussed: hypoglycemia, therapy, care home diabetes, influence of comorbidities, glucose targets, family/carer perspectives, diabetes education, and patient safety. A set of "consensus" statements was produced in each domain of interest. These form a foundation for future policy development in this area and should influence the clinical behavior and approach of all health professionals engaged in delivering diabetes care to older people.